Molica M, Miralles G, Dillon R, Annunziata M, et al. Effectiveness of Gilteritinib Beyond Second-Line Therapy in Relapsed/Refractory FLT3-Mutated Acute Myeloid Leukemia: A Real-World Multicenter Study of 171 Patients. Am J Hematol 2025 Nov 22. doi: 10.1002/ajh.70142.
PMID: 41273181